IRCT20201227049851N1
Recruiting
Phase 3
Efficacy of Memantine augmentation in moderate to severe obsessive-compulsive symptoms
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Obsessive-compulsive disorder.
- Sponsor
- Kashan University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients who suffer from obsessive\-compulsive disorder according to DSM V and clinical interview.
- •Patients who have Yale\-Brown Scores of 15 and above.
- •Patients who give written consent for participating in the study.
Exclusion Criteria
- •Patients who are diagnosed with a comorbid DSM V psychiatric diagnosis.
- •Patients who suffer from any systemic disease such as diabetes, hypo and hyperthyroidism,hypertension,hepatic failure or renal failure.
- •Patients who use alcohol or any other substance.
- •Patients who have received a psychotropic medicine during the last 6 months.
- •Women who are pregnant or breastfeeding or do not use any certain contraceptive method.
- •Patients who use concomitant somatic treatments.
- •Patients who are under treatment with Acetyl Cysteine, buprenorphine or any other medicine
- •Patients who receive any kind of psychotherapies.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Study of the efficacy of memantine in metastatic colon canceIRCT20210819052230N1Oroumia University of Medical Sciences50
Completed
Not Applicable
Efficacy of memantine in patients with moderate-to-severe Alzheimer's disease: results of pooled analysis, using realistic definitions of response, of two randomized, double-blind, placebo-controlled trials in JapaAlzheimer's diseaseJPRN-UMIN000026013Daiichi Sankyo Co., LTD.633
Recruiting
Not Applicable
Memantine for treatment of Obsessive-Compulsive DisorderIRCT20170123032145N4Iran University of Medical Sciences44
Not yet recruiting
Not Applicable
An investigation on the effect of memantine on children with autistic spectrum disorderIRCT20211118053097N1Shiraz University of Medical Sciences52
Completed
Phase 2
The efficacy of complementory use of memantine in treatment of schizophrenia with chronic courseSchizophrenia.SchizophreniaIRCT201306015605N1Clinical psychiatry research center, Tabriz university of medical sciences60